Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Cross HealthNZSE:GXH 64 ROC (Joel Greenblatt) % is 41.63% as of Mar. 2026, which is 16% above its 10-year median of 35.90. GuruFocus rates NZSE:GXH with a GF Score™ of 64/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Green Cross Health ranks better than 73.24% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Green Cross Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 41.63%.
The historical rank and industry rank for Green Cross Health's ROC (Joel Greenblatt) % or its related term are showing as below:
NZSE:GXH'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 22.28 Med: 35.9 Max: 169.94
Current: 32.48
During the past 13 years, Green Cross Health's highest ROC (Joel Greenblatt) % was 169.94%. The lowest was 22.28%. And the median was 35.90%.
NZSE:GXH's ROC (Joel Greenblatt) % is ranked better than 73.24% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.73
vs NZSE:GXH: 32.48
Green Cross Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -4.10% per year.
Green Cross Health (NZSE:GXH) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Green Cross Health ROC (Joel Greenblatt) % Related Terms
Green Cross Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Green Cross Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Green Cross Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Health ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Green Cross Health's ROC (Joel Greenblatt) % falls into.
Green Cross Health ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 41.63% mean?
Green Cross Health (NZSE:GXH) has a ROC (Joel Greenblatt) % of 41.63% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Green Cross Health and its competitors. This is 16% above median its historical median of 35.90. Over the past decade, Green Cross Health's ROC (Joel Greenblatt) % has ranged from 22.28 to 169.94. According to the industry distribution chart, Green Cross Health ranks #179 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 26.8%.
Is Green Cross Health's ROC (Joel Greenblatt) % too high?
Green Cross Health's current ROC (Joel Greenblatt) % of 41.63% is 16% above median its 10-year median of 35.90. Over the past 10 years, this metric has ranged from a low of 22.28 to a high of 169.94. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.73. Green Cross Health's value of 41.63% is 227% above this industry median. Based on the distribution chart, Green Cross Health ranks #179 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Green Cross Health has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Green Cross Health ranks #179 out of 669 companies for ROC (Joel Greenblatt) %. This puts Green Cross Health in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.73. Green Cross Health's value of 41.63% is 227% above this benchmark. Historically, Green Cross Health's own ROC (Joel Greenblatt) % has ranged from 22.28 to 169.94 over the past decade. While the company's 10-year median is 35.90 vs. the industry median of 12.73, Green Cross Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.73, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Cross Health's current ROC (Joel Greenblatt) % of 41.63% is 227% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Green Cross Health and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Cross Health's current ROC (Joel Greenblatt) % is 41.63%, which is 16% above median its own 10-year median of 35.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$1.92 — trading 77.8% above its estimated fair value. The current ROC (Joel Greenblatt) % is 41.63%, which is 16% above median its 10-year median of 35.90 and 227% above the Healthcare Providers & Services industry median of 12.73. Green Cross Health's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current ROC (Joel Greenblatt) % is 41.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Cross Health (NZSE:GXH) Overvalued in 2026?
Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued.
The current stock price of NZ$1.92 is trading 77.8% above its estimated GF Value™ of NZ$1.08.
GuruFocus considers Green Cross Health to be Significantly Overvalued.
Key valuation signals for NZSE:GXH:
ROC (Joel Greenblatt) %: 41.63% (16% above median its 10-year median of 35.90)
GF Value™: NZ$1.08 vs. price of NZ$1.92 (77.8% above fair value)
Industry Position: 227% above the Healthcare Providers & Services median (#179 of 669)
No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
64GF Score
Get the complete analysis for NZSE:GXH
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:GXH has been successfully added to your 
